Cargando…

The unmet need for better risk stratification of non‐proliferative diabetic retinopathy

Diabetic retinopathy is a common microvascular complication of diabetes and remains one of the leading causes of preventable blindness in working‐age people. Non‐proliferative diabetic retinopathy is the earliest stage of diabetic retinopathy and is typically asymptomatic. Currently, the severity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivaprasad, S., Pearce, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587728/
https://www.ncbi.nlm.nih.gov/pubmed/30474144
http://dx.doi.org/10.1111/dme.13868
_version_ 1783429125084545024
author Sivaprasad, S.
Pearce, E.
author_facet Sivaprasad, S.
Pearce, E.
author_sort Sivaprasad, S.
collection PubMed
description Diabetic retinopathy is a common microvascular complication of diabetes and remains one of the leading causes of preventable blindness in working‐age people. Non‐proliferative diabetic retinopathy is the earliest stage of diabetic retinopathy and is typically asymptomatic. Currently, the severity of diabetic retinopathy is assessed using semi‐quantitative grading systems based on the presence or absence of retinal lesions. These methods are well validated, but do not predict those at high risk of rapid progression to sight‐threatening diabetic retinopathy; therefore, new approaches for identifying these people are a current unmet need. We evaluated published data reporting the lesion characteristics associated with different progression profiles in people with non‐proliferative diabetic retinopathy. Based on these findings, we propose that additional assessments of features of non‐proliferative diabetic retinopathy lesions may help to stratify people based on the likelihood of rapid progression. In addition to the current classification, the following measurements should be considered: the shape and size of lesions; whether lesions are angiogenic in origin; the location of lesions, including predominantly peripheral lesions; and lesion turnover and dynamics. For lesions commonly seen in hypertensive retinopathy, a detailed assessment of potential concomitant diseases is also recommended. We believe that natural history studies of these changes will help characterize these non‐proliferative diabetic retinopathy progression profiles and advance our understanding of the pathogenesis of diabetic retinopathy in order to individualize management of people with diabetic retinopathy.
format Online
Article
Text
id pubmed-6587728
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65877282019-07-02 The unmet need for better risk stratification of non‐proliferative diabetic retinopathy Sivaprasad, S. Pearce, E. Diabet Med Review Articles Diabetic retinopathy is a common microvascular complication of diabetes and remains one of the leading causes of preventable blindness in working‐age people. Non‐proliferative diabetic retinopathy is the earliest stage of diabetic retinopathy and is typically asymptomatic. Currently, the severity of diabetic retinopathy is assessed using semi‐quantitative grading systems based on the presence or absence of retinal lesions. These methods are well validated, but do not predict those at high risk of rapid progression to sight‐threatening diabetic retinopathy; therefore, new approaches for identifying these people are a current unmet need. We evaluated published data reporting the lesion characteristics associated with different progression profiles in people with non‐proliferative diabetic retinopathy. Based on these findings, we propose that additional assessments of features of non‐proliferative diabetic retinopathy lesions may help to stratify people based on the likelihood of rapid progression. In addition to the current classification, the following measurements should be considered: the shape and size of lesions; whether lesions are angiogenic in origin; the location of lesions, including predominantly peripheral lesions; and lesion turnover and dynamics. For lesions commonly seen in hypertensive retinopathy, a detailed assessment of potential concomitant diseases is also recommended. We believe that natural history studies of these changes will help characterize these non‐proliferative diabetic retinopathy progression profiles and advance our understanding of the pathogenesis of diabetic retinopathy in order to individualize management of people with diabetic retinopathy. John Wiley and Sons Inc. 2018-12-07 2019-04 /pmc/articles/PMC6587728/ /pubmed/30474144 http://dx.doi.org/10.1111/dme.13868 Text en © 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Review Articles
Sivaprasad, S.
Pearce, E.
The unmet need for better risk stratification of non‐proliferative diabetic retinopathy
title The unmet need for better risk stratification of non‐proliferative diabetic retinopathy
title_full The unmet need for better risk stratification of non‐proliferative diabetic retinopathy
title_fullStr The unmet need for better risk stratification of non‐proliferative diabetic retinopathy
title_full_unstemmed The unmet need for better risk stratification of non‐proliferative diabetic retinopathy
title_short The unmet need for better risk stratification of non‐proliferative diabetic retinopathy
title_sort unmet need for better risk stratification of non‐proliferative diabetic retinopathy
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587728/
https://www.ncbi.nlm.nih.gov/pubmed/30474144
http://dx.doi.org/10.1111/dme.13868
work_keys_str_mv AT sivaprasads theunmetneedforbetterriskstratificationofnonproliferativediabeticretinopathy
AT pearcee theunmetneedforbetterriskstratificationofnonproliferativediabeticretinopathy
AT sivaprasads unmetneedforbetterriskstratificationofnonproliferativediabeticretinopathy
AT pearcee unmetneedforbetterriskstratificationofnonproliferativediabeticretinopathy